
    
      Combined 3-part study. Part-1: Single Ascending dose study. Part-2: Multiple Ascending Dose
      Study Part-3: Optional relative bioavailability and food effect study. Part-1 and 2 are
      double blind sponsor open and Part-3 is open label cross over study.
    
  